Cargando…

In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs

The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires treatments with rapid clinical translatability. Here we develop a multi-target and multi-ligand virtual screening method to identify FDA-approved drugs with potential activity against SARS-CoV-2 at t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Wallace K. B., Olson, Keith M., Wotring, Jesse W., Sexton, Jonathan Z., Carlson, Heather A., Traynor, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963407/ https://www.ncbi.nlm.nih.gov/pubmed/35351926 http://dx.doi.org/10.1038/s41598-022-08320-y

Ejemplares similares

Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern
por: Wotring, Jesse W., et al.
Publicado: (2022)

Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection
por: Qiao, Yuanyuan, et al.
Publicado: (2023)

ARF6 is a host factor for SARS-CoV-2 infection in vitro
por: Mirabelli, C., et al.
Publicado: (2023)

Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19
por: Mirabelli, Carmen, et al.
Publicado: (2020)

In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach
por: Zhang, Yiming, et al.
Publicado: (2021)

Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
por: Qiao, Yuanyuan, et al.
Publicado: (2023)

Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
por: Mirabelli, Carmen, et al.
Publicado: (2021)

An in silico map of the SARS-CoV-2 RNA Structurome
por: Andrews, Ryan J., et al.
Publicado: (2020)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

An ayurvedic perspective along with in silico study of the drugs for the management of SARS-CoV-2
por: Gandhi, Abhay Jayprakash, et al.
Publicado: (2022)

In Silico Screening of the DrugBank Database to Search for Possible Drugs against SARS-CoV-2
por: Cuesta, Sebastián A., et al.
Publicado: (2021)

Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
por: Chen, Chenxiao, et al.
Publicado: (2022)

Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
por: Xue, Yiying, et al.
Publicado: (2023)

Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study
por: Nag, Anish, et al.
Publicado: (2021)

Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach
por: Sahoo, Alaka, et al.
Publicado: (2021)

In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing
por: Abdelkader, Ahmed, et al.
Publicado: (2022)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)

In silico antibody engineering for SARS-CoV-2 detection
por: Martí, Didac, et al.
Publicado: (2021)

TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform
por: Peiffer, Amanda L., et al.
Publicado: (2023)

Comparative analysis of non structural protein 1 of SARS-CoV2 with SARS-CoV1 and MERS-CoV: An in silico study
por: Chaudhuri, Ankur
Publicado: (2021)

A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development
por: Abdulla, Zainalabideen A., et al.
Publicado: (2021)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
por: Wei, Tian-zi, et al.
Publicado: (2020)

Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking
por: Ibrahim, Tamer M., et al.
Publicado: (2020)

Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach
por: Singh, Sanjay Kumar, et al.
Publicado: (2021)

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
por: Ramírez-Salinas, Gema Lizbeth, et al.
Publicado: (2020)

Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study
por: Akinlalu, Alfred Olaoluwa, et al.
Publicado: (2021)

In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
por: Zapata-Cardona, Maria I., et al.
Publicado: (2023)

SABRes: in silico detection of drug resistance conferring mutations in subpopulations of SARS-CoV-2 genomes
por: Fong, Winkie, et al.
Publicado: (2023)

Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes
por: Yao, Yi, et al.
Publicado: (2022)

Laboratory diagnosis of SARS-CoV-2: available approaches and limitations
por: Abduljalil, J.M.
Publicado: (2020)

Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
por: Chaudhry, M. Zeeshan, et al.
Publicado: (2022)

In Silico Study of Mutational Stability of SARS-CoV-2 Proteins
por: Chaudhuri, Dwaipayan, et al.
Publicado: (2021)

Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
por: Rolta, Rajan, et al.
Publicado: (2022)

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
por: Campione, Elena, et al.
Publicado: (2021)

Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020)

In-silico approach to designing effective antiviral drugs against SARS-CoV-2 and SARS-CoV-1 from reported phytochemicals: a quality improvement study
por: Tuz-Zohura, Fatema-, et al.
Publicado: (2023)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

SARS-CoV-2 Virology
por: Li, Yijia, et al.
Publicado: (2022)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
por: Al-Sehemi, Abdullah G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lis28r57hcuk3fkd0kdtfcgidr